Scarica l'app Stockscreener
5.72
0.00%
0.00
Pre-mercato:
5.72
Nevro Corp Borsa (NVRO) Ultime notizie
Nevro (NVRO) to Release Earnings on Wednesday - MarketBeat
Nevro (NYSE:NVRO) Price Target Raised to $5.85 - MarketBeat
Nevro (NYSE:NVRO) Upgraded by Piper Sandler to "Overweight" Rating - MarketBeat
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain? - Yahoo Finance
Globus Medical strengthens SCS market position with $250m Nevro deal - Yahoo Finance
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp.NVRO - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVRO, SLRN, PLYA on Behalf of Shareholders - Marketscreener.com
Jefferies raises Nevro stock rating, boosts price target to $5.85 - MSN
Stifel maintains GMED buy rating, $92 target amid NVRO buyout - MSN
Jefferies Upgrades Nevro to Hold From Underperform, Adjusts Price Target to $5.85 From $4.50 - Marketscreener.com
Jefferies raises Nevro stock rating, boosts price target to $5.85 By Investing.com - Investing.com Australia
Nevro (NYSE:NVRO) Stock Rating Upgraded by Jefferies Financial Group - MarketBeat
Needham maintains hold on Globus Medical stock post-acquisition - MSN
Jefferies Upgrades Nevro Corp (NVRO) to Hold - StreetInsider.com
Globus Medical to Acquire Nevro Corp. in Strategic $250 Million Deal - MSN
Jefferies maintains Buy on Globus Medical, target at $105 - MSN
Globus Medical Enters into Merger Agreement with Nevro Corp. - Armenian Reporter
Globus Medical to acquire Nevro for $5.85 per share - MSN
Brokerages Set Nevro Corp. (NYSE:NVRO) PT at $6.30 - MarketBeat
Piper Sandler Upgrades Nevro (NVRO) - Nasdaq
Demystifying Nevro: Insights From 11 Analyst Reviews - Benzinga
Nevro (NVRO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Nevro upgraded to Neutral from Underweight at Piper Sandler - MSN
Piper Sandler Upgrades Nevro to Neutral From Underweight, Adjusts Price Target to $5.85 From $6 - Marketscreener.com
Globus Medical, Inc. entered into a definitive agreement to acquire Nevro Corp. for approximately $250 million. - Marketscreener.com
Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock? - Yahoo Finance
Altus Power, Amazon, Nevro - TradingView
Piper Sandler raises Nevro stock to Neutral, cuts target to $5.85 - MSN
Globus Medical to acquire Nevro for $250 million By Investing.com - Investing.com Nigeria
Piper Sandler Upgrades Nevro Corp (NVRO) to Neutral - StreetInsider.com
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Nevro Corp.NVRO - The Malaysian Reserve
Globus Medical to Acquire Nevro for $250M - MD+DI
Items Tagged with 'joint fusion' - BioWorld Online
Globus Medical buying chronic pain company Nevro for $250M - BioWorld Online
Latham & Watkins Advises Nevro in Acquisition by Globus Medical - Latham & Watkins LLP
BTIG maintains $91 target on Globus Medical stock post-acquisition - MSN
Globus Medical Announces Acquisition of Nevro Corp - TipRanks
Canaccord maintains Buy rating, $101 target on Globus Medical stock - MSN
Nevro Corp Announces Merger Agreement with Globus Medical - TipRanks
Globus Medical Buys Device Maker Nevro In $250M Deal - Law360
Globus Medical to acquire Nevro for $250 million - MSN
Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio - Yahoo Finance
Globus Medical to buy California life sciences firm for $250M - The Business Journals
Globus Medical To Acquire Nevro For $250 Mln - Nasdaq
Nevro Corp (NVRO) PT Raised to $5.85 at Canaccord Genuity - StreetInsider.com
NVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Nevro Corp. Is Fair to Shareholders - Business Wire
Globus Medical to acquire Nevro for $250M - Mass Device
Shareholder Alert: Ademi & Fruchter LLP Investigates Whether Nevro Corp. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Globus Medical to Acquire Nevro -February 06, 2025 at 09:58 am EST - Marketscreener.com
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - GlobeNewswire
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - Benzinga
Major Medical Device Acquisition: Globus Medical Takes Over Nevro in Strategic $250M Pain Tech Deal - StockTitan
Nevro (NVRO) Cash-to-Debt : 1.12 (As of Sep. 2024) - GuruFocus.com
Here's Why you Should Add Nevro Stock to Your Portfolio Now - MSN
Chronic Pain Associated With Painful Diabetic Neuropathy Market Growth Projections 2023-2032: DelveInsight Analysis | AstraZeneca, Regenacy Pharma, Nevro Corp., Erchonia Corporation - The Globe and Mail
0.38%
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):